Medicofarma Biotech SA

WAR:MDB (Poland)   Ordinary Shares
zł 0.84 (+7.44%) May 29
At Loss
P/B:
6.24
Market Cap:
zł 56.97M ($ 14.37M)
Enterprise V:
zł 56.91M ($ 14.35M)
Volume:
4.85K
Avg Vol (2M):
11.29K
Volume:
4.85K
At Loss
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Medicofarma Biotech SA ( ) from 2008 to May 30 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Medicofarma Biotech stock (WAR:MDB) PE ratio as of May 30 2024 is 0. More Details

Medicofarma Biotech SA (WAR:MDB) PE Ratio (TTM) Chart

To

Medicofarma Biotech SA (WAR:MDB) PE Ratio (TTM) Historical Data

Total 1248
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Medicofarma Biotech PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-30 At Loss 2024-03-26 At Loss
2024-05-29 At Loss 2024-03-25 At Loss
2024-05-28 At Loss 2024-03-22 At Loss
2024-05-27 At Loss 2024-03-21 At Loss
2024-05-24 At Loss 2024-03-20 At Loss
2024-05-23 At Loss 2024-03-19 At Loss
2024-05-22 At Loss 2024-03-18 At Loss
2024-05-21 At Loss 2024-03-15 At Loss
2024-05-20 At Loss 2024-03-14 At Loss
2024-05-17 At Loss 2024-03-13 At Loss
2024-05-16 At Loss 2024-03-12 At Loss
2024-05-15 At Loss 2024-03-11 At Loss
2024-05-14 At Loss 2024-03-08 At Loss
2024-05-13 At Loss 2024-03-07 At Loss
2024-05-10 At Loss 2024-03-06 At Loss
2024-05-09 At Loss 2024-03-05 At Loss
2024-05-08 At Loss 2024-03-04 At Loss
2024-05-07 At Loss 2024-03-01 At Loss
2024-05-06 At Loss 2024-02-29 At Loss
2024-05-02 At Loss 2024-02-28 At Loss
2024-04-30 At Loss 2024-02-27 At Loss
2024-04-29 At Loss 2024-02-26 At Loss
2024-04-26 At Loss 2024-02-23 At Loss
2024-04-25 At Loss 2024-02-22 At Loss
2024-04-24 At Loss 2024-02-21 At Loss
2024-04-23 At Loss 2024-02-20 At Loss
2024-04-22 At Loss 2024-02-19 At Loss
2024-04-19 At Loss 2024-02-16 At Loss
2024-04-18 At Loss 2024-02-15 At Loss
2024-04-17 At Loss 2024-02-14 At Loss
2024-04-16 At Loss 2024-02-13 At Loss
2024-04-15 At Loss 2024-02-12 At Loss
2024-04-12 At Loss 2024-02-09 At Loss
2024-04-11 At Loss 2024-02-08 At Loss
2024-04-10 At Loss 2024-02-07 At Loss
2024-04-09 At Loss 2024-02-06 At Loss
2024-04-08 At Loss 2024-02-05 At Loss
2024-04-05 At Loss 2024-02-02 At Loss
2024-04-04 At Loss 2024-02-01 At Loss
2024-04-03 At Loss 2024-01-31 At Loss
2024-04-02 At Loss 2024-01-30 At Loss
2024-04-01 At Loss 2024-01-29 At Loss
2024-03-29 At Loss 2024-01-26 At Loss
2024-03-28 At Loss 2024-01-25 At Loss
2024-03-27 At Loss 2024-01-24 At Loss

Medicofarma Biotech SA (WAR:MDB) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Medicofarma Biotech SA operates in the pharmaceutical industry. The company specializes in contract manufacturing of medical devices, medicinal products and dietary supplements. The business is spread across Austria, Czech Republic, Spain, Ireland, Canada, Germany, Norway, Sweden, Great Britain, and Italy.